Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of Use
1993 • 4,259 citations
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
1999 • 994 citations
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
1998 • 857 citations
Inhibitory Effect of Tumor Metastasis in Mice by Saponins, Ginsenoside-Rb2, 20(R)- and 20(S)-Ginsenoside-Rg3, of Red ginseng.
1995 • 376 citations
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.
1998 • 334 citations
Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer
1998 • 297 citations
Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.
1997 • 215 citations
Inhibition of Tumor Angiogenesis and Metastasis by a Saponin of Panax ginseng, Ginsenoside-Rb2.
1994 • 211 citations
Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
1986 • 190 citations
Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines
1994 • 181 citations
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer
1998 • 181 citations
Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives
1992 • 174 citations
Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
1996 • 126 citations
PREVALENCE AND PATTERNS OF THE USE OF COMPLEMENTARY THERAPIES AMONG PROSTATE CANCER PATIENTS: AN EPIDEMIOLOGICAL ANALYSIS
1999 • 126 citations
Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines
1996 • 113 citations
Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8)
1989 • 106 citations
PC‐SPES, a dietary supplement for the treatment of hormone‐refractory prostate cancer
2000 • 94 citations
Antitumor Active Polysaccharides from the Chinese MushroomSongshan Lingzhi, the Fruiting Body ofGanoderma tsugae
1993 • 94 citations
Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin.
1989 • 89 citations
Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens.
1983 • 87 citations
PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
2000 • 84 citations
A PHASE 1-2 TRIAL OF DIETHYLSTILBESTROL PLUS LOW DOSE WARFARIN IN ADVANCED PROSTATE CARCINOMA
1999 • 81 citations
Effects of a phytotherapeutic agent, PC‐SPES, on prostate cancer: a preliminary investigation on human cell lines and patients
1999 • 72 citations
Inhibition of Mutagenicity inSalmonella typhimuriumbyGlycyrrhiza glabraExtract, Glycyrrhizinic Acid and 18α- and 18β-Glycyrrhetinic Acids
1993 • 71 citations
Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen‐responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC‐SPES
1997 • 70 citations
In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells
1996 • 66 citations
Steroid hormone-binding proteins in blood plasma
1972 • 65 citations
Reversal of Daunomycin and Vinblastine Resistance in Multidrug-Resistant P388 Leukemiain vitrothrough Enhanced Cytotoxicity by Triterpenoids
1995 • 60 citations
Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.
1999 • 58 citations
Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells
1994 • 58 citations
Antitumor activity of Sarcodon aspratus (BERK.) S. ITO and Ganoderma lucidum (FR.) KARST.
1989 • 55 citations
Antitumor Active Protein-containing Glycans from the Chinese Mushroom Songshan Lingzhi,Ganoderma tsugaeMycelium
1994 • 55 citations
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease
1999 • 41 citations
A Modification of Simon's Optimal Design for Phase II Trials When the Criterion Is Median Sample Size
1999 • 29 citations
Effects of Ganoderma Lucidum and Krestin on Cellular Immunocompetence in γ-Ray-irradiated Mice
1995 • 28 citations
Idiopathic Thromboembolism as the Presenting Sign of Occult Prostate Cancer
1998 • 18 citations
Acid phosphatase: defining a role in androgen-independent prostate cancer
1996 • 15 citations
Survey of UsToo Members and Other Prostate Cancer Patients to Evaluate the Efficacy and Safety of PC-SPES.
1999 • 14 citations
Effect of glycyrrhetinic acid on DNA damage and unscheduled DNA synthesis induced by benzo(a)pyrene.
1995 • 8 citations
Cited By (0)
No citing papers found in database